Who
Sam Samad
Executive Vice President & CFO
Company insider
Files Form 4 as: Executive Vice President & CFO, Quest Diagnostics; Director, IDEXX Laboratories; SVP and CFO, Illumina.
In numbers
- Trades disclosed
- 99
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $2.3M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 6 Jan 2017
- Last trade
- 22 Jul 2026
- Last filed
- 27 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 27 Jul 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $21K102 at $206.81 | filing |
| 22 Jul 2026filed 27 Jul 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $21K102 at $206.81 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —525 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —234 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —525 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —234 at $0.00 | filing |
| 20 Apr 2026filed 24 Apr 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $21K108 at $194.70 | filing |
| 20 Apr 2026filed 24 Apr 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $21K108 at $194.70 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $2.9M13,947 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $1.6M7,720 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $2.9M13,947 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $1.6M7,720 at $204.86 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $178K869 at $204.86 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $178K869 at $204.86 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —3,965 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $180K855 at $210.01 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $209K1,010 at $206.99 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —18,303 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —18,303 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —3,965 at $0.00 | filing |
News
Illumina To Webcast Upcoming Investor ConferenceILMN · prnewswire.com · 20 Oct 2026Illumina's (ILMN) Sequencing Business Is Recovering, But Is the Stock Getting Ahead of Itself?ILMN · insidermonkey.com · 13 Oct 2026Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysILMN · themarketsdaily.com · 7 Oct 2026
0 headlines in the last 90 days name Sam Samad; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.